Navigation Links
SCAI Statement on the Hospitalization of Former President Bill Clinton

WASHINGTON, Feb. 12 /PRNewswire/ -- Members of the interventional cardiology community wish former President Bill Clinton a quick recovery following his recent hospitalization for angioplasty and stenting.

Like many heart patients, Mr. Clinton has communicated a desire to return to work promptly. Because angioplasty procedures are performed percutaneously, without major surgery to open the chest, most patients who receive coronary stents leave the hospital within one to two days and promptly return to the activities they love. 

News of Mr. Clinton's treatment serves as a reminder of the importance of utilizing the full range of medical and device treatments for patients with heart disease. Medication, angioplasty, stents and bypass surgery all play a key role – often complementing one another – in treating and saving thousands of heart patients' lives each year. Like Mr. Clinton, many patients taking the appropriate prescribed medications find that additional treatment may be needed to reduce debilitating symptoms like chest pain.

Mr. Clinton's experience also demonstrates how important it is for patients to listen to their body's warning signals. Mr. Clinton's quick response to his symptoms led to prompt and effective care and may have prevented a much more serious incident. All cardiac patients should be aware that heart disease is chronic – that the disease often progresses even after successful revascularization procedures such as bypass surgery, which Mr. Clinton underwent six years ago. Drug-eluting stents, now commonly used for percutaneous procedures, have further reduced the risk of needing another procedure compared to older stent technology.

Cardiovascular disease remains the leading killer of both men and women in America. It is only through continued innovation and access to the full range of treatment options that we can effectively battle cardiovascular disease for all patients – those who are at risk, those who suffer from stable chest pain, and those who experience heart attack.

About SCAI

Headquartered in Washington, D.C., the Society for Cardiovascular Angiography and Interventions is a 4,000-member professional organization representing invasive and interventional cardiologists in more than 60 nations. SCAI's mission is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's patient and physician education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit or




Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oramed Pharmaceuticals Announces Filing of Two Registration Statements
2. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at
4. Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse
5. Sinovac Files Shelf Registration Statement
6. Derma Sciences Files S-1 Registration Statement
7. Neuro Kinetics Statement Concerning Newspaper Article
8. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
9. Statement of Americas Specialty Medicines Companies On House Health Care Bill (H.R. 3962)
10. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
11. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... (PRWEB) , ... November 28, 2015 , ... There is ... we outperform our billings from last year? , This question has not been an ... are coming to the retirement age and the younger workforce don’t share the same ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at ... people age, more care is needed, especially with Alzheimer’s, dementia and other cognitive ... being overworked. The forgotten part of this equation: 80 percent of medical care ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
Breaking Medicine News(10 mins):